Nektar TherapeuticsNKTRNASDAQ
LOADING
|||
Operating Income Scaling
Trending higher, above historical average, strong compound growth.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-105.20M
↑ 17% above average
Average (9y)
$-126.29M
Historical baseline
Range
High:$687.93M
Low:$-446.10M
CAGR
+15.2%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-105.20M | +23.5% |
| 2023 | $-137.43M | +42.8% |
| 2022 | $-240.24M | +46.1% |
| 2021 | $-446.10M | -17.4% |
| 2020 | $-379.92M | +13.7% |
| 2019 | $-440.04M | -164.0% |
| 2018 | $687.93M | +1253.4% |
| 2017 | $-59.64M | +47.2% |
| 2016 | $-112.86M | -284.2% |
| 2015 | $-29.37M | - |